Viewing Study NCT01398592


Ignite Creation Date: 2025-12-24 @ 3:35 PM
Ignite Modification Date: 2026-01-07 @ 7:27 PM
Study NCT ID: NCT01398592
Status: COMPLETED
Last Update Posted: 2013-02-12
First Post: 2011-07-15
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Vildagliptin Versus Sitagliptin - Differences in Fasting Plasma Glucose Lowering Efficacy
Sponsor: Novartis Pharmaceuticals
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2011-06
Start Date Type: None
Primary Completion Date: 2012-06
Primary Completion Date Type: ACTUAL
Completion Date: 2012-06
Completion Date Type: ACTUAL
First Submit Date: 2011-07-15
First Submit QC Date: None
Study First Post Date: 2011-07-20
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2013-02-11
Last Update Post Date: 2013-02-12
Last Update Post Date Type: ESTIMATED